Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/17/2011 | WO2011140639A1 Modulation of scleraxis using a dominant negative scleraxis mutant with a basic dna-binding domain deletion |
11/17/2011 | WO2011090684A3 Methods for developing endothelial cells from pluripotent cells and endothelial cells derived |
11/17/2011 | WO2011089170A3 Process for preparing fgf-21 with low degree of o-glycosylation |
11/17/2011 | WO2011084647A3 Toxin-immunity system |
11/17/2011 | WO2011084324A3 Novel bacillus thuringiensis gene with lepidopteran activity |
11/17/2011 | WO2011081366A3 Beef-specific age determination marker containing the p21 protein |
11/17/2011 | WO2011077133A3 Method of treatment and screening method |
11/17/2011 | WO2010139469A8 Antibodies against human ccn1 and uses thereof |
11/17/2011 | WO2010136562A3 Moraxella catarrhalis antigens |
11/17/2011 | WO2010109053A8 Methods and compositions for the treatment of cirrhosis and liver fibrosis |
11/17/2011 | US20110283426 Isolated nucleic acid molecules from the genome of citrus leprosis virus and uses thereof |
11/17/2011 | US20110283417 Secreted Insecticidal Protein and Gene Compositions from Bacillus Thuringiensis and Uses Therefor |
11/17/2011 | US20110283414 Soybean Cultivar 95092896 |
11/17/2011 | US20110283413 Soybean Cultivar 99497033 |
11/17/2011 | US20110283412 Plants and seeds of hybrid corn variety ch812985 |
11/17/2011 | US20110283401 Soybean Cultivar S090243 |
11/17/2011 | US20110283400 Soybean cultivar 92394228 |
11/17/2011 | US20110283399 Soybean cultivar 98433118 |
11/17/2011 | US20110283398 Soybean cultivar 96462908 |
11/17/2011 | US20110283397 Plants and seeds of hybrid corn variety ch396198 |
11/17/2011 | US20110283396 Plants and seeds of hybrid corn variety ch957322 |
11/17/2011 | US20110283395 Plants and seeds of hybrid corn variety ch434101 |
11/17/2011 | US20110283394 Plants and seeds of hybrid corn variety ch918848 |
11/17/2011 | US20110283393 Soybean cultivar s090253 |
11/17/2011 | US20110283392 Soybean cultivar 97274007 |
11/17/2011 | US20110283391 Soybean Cultivar 90362556 |
11/17/2011 | US20110283390 Soybean Cultivar 96292716 |
11/17/2011 | US20110283389 Soybean Cultivar 99466158 |
11/17/2011 | US20110283388 Soybean Cultivar 93397033 |
11/17/2011 | US20110283387 Soybean Cultivar 90202016 |
11/17/2011 | US20110283386 Soybean Cultivar S090250 |
11/17/2011 | US20110283385 Plants and seeds of corn variety cv032267 |
11/17/2011 | US20110283382 Plants and seeds of corn variety cv556014 |
11/17/2011 | US20110283381 Plants and seeds of corn variety cv353100 |
11/17/2011 | US20110283380 Plants and seeds of corn variety cv502609 |
11/17/2011 | US20110283379 Plants and seeds of corn variety cv385683 |
11/17/2011 | US20110282032 Process for highly selective purification of two plasma proteins: von willebrand factor (vwf) and fibronectin (fn) |
11/17/2011 | US20110282031 A1 adenosine receptor diagnostic probes |
11/17/2011 | US20110282030 Naturiuretic polypeptides |
11/17/2011 | US20110282029 Novel peptides that bind to the erythropoietin receptor |
11/17/2011 | US20110281939 Polynucleotide aptamer-based cross-linked materials and uses thereof |
11/17/2011 | US20110281856 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates |
11/17/2011 | US20110281803 Sulfatase enzymes |
11/17/2011 | US20110281800 Recombinant fusion proteins to growth hormone and serum albumin |
11/17/2011 | US20110281799 Vascular Endothelial Growth Factor D (VEGF-D) Antibodies and Vectors, and Methods of Uses |
11/17/2011 | US20110281797 Site-specific monoconjugated insulinotropic glp-1 peptides |
11/17/2011 | US20110281796 Novel activin receptor and uses thereof |
11/17/2011 | US20110281792 Binding-site modified lectins and uses thereof |
11/17/2011 | US20110281791 Crystalline insulin-conjugates |
11/17/2011 | US20110281789 Ulbp antibodies |
11/17/2011 | US20110281786 Stem cell expansion enhancing factor and method of use |
11/17/2011 | US20110281767 Compositions and methods for molecular biology |
11/17/2011 | US20110281349 Insect Desiccation Resistance Genes and Uses Thereof |
11/17/2011 | US20110281302 Compositions and methods of treating disease with fgfr fusion proteins |
11/17/2011 | US20110281299 Recombinant Pokeweed Antiviral Proteins, Compositions and Methods Related Thereto |
11/17/2011 | US20110281292 Compositions and methods for identifying antigens which elicit an immune response |
11/17/2011 | US20110281284 Novel liver cancer marker |
11/17/2011 | US20110281258 Human Immunodeficiency Virus And Uses Thereof |
11/17/2011 | US20110280948 Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins |
11/17/2011 | US20110280914 Hydrogels crosslinked with gold nanoparticles and methods of making and using thereof |
11/17/2011 | US20110280910 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
11/17/2011 | US20110280908 Multimeric protein toxins to target cells having multiple identifying characteristics |
11/17/2011 | US20110280902 Compounds and methods for diagnosis and treatment of leishmaniasis |
11/17/2011 | US20110280901 Diagnosis and treatment of Trypanosoma cruzi infection and chagas disease |
11/17/2011 | US20110280900 Clostridium chauvoei polypeptide, dna encoding the polypeptide and a vaccine comprising the polypeptide |
11/17/2011 | US20110280899 Novel Immunogenic Lipopeptides Comprising T-Helper And Cytotoxic T-Lymphocyte (CTL) Epitopes |
11/17/2011 | US20110280897 Polypeptides and uses thereof |
11/17/2011 | US20110280894 Her2/neu specific t cell receptors |
11/17/2011 | US20110280889 High affinity t cell receptor and use thereof |
11/17/2011 | US20110280885 Cancer immunotherapy |
11/17/2011 | US20110280882 Leukolectins and uses thereof |
11/17/2011 | US20110280879 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
11/17/2011 | US20110280876 Mutated netrin - 4, fragments thereof and their use as medicines |
11/17/2011 | US20110280865 Ets-2 Biomarkers for Fibrotic Diseases and Uses Thereof |
11/17/2011 | US20110280863 Methods and compositions for the detection and treatment of preeclampsia |
11/17/2011 | US20110280856 Treatment of alpha-galactosidase a deficiency |
11/17/2011 | US20110280841 Electroprocessing in Drug Delivery and Cell Encapsulation |
11/17/2011 | US20110280830 Albumin Fusion Proteins |
11/17/2011 | US20110280826 Y-shaped polyethylene glycol modified g-csf, the preparation and use thereof |
11/17/2011 | US20110280806 Dye conjugate imaging agents |
11/17/2011 | US20110280802 Linkers For Radiopharmaceutical Compounds |
11/17/2011 | CA2800610A1 Differentiation of human embryonic stem cells |
11/17/2011 | CA2799470A1 Humanized ttc and methods of use thereof |
11/17/2011 | CA2799192A1 Improved complement receptor 2 (cr2) targeting groups |
11/17/2011 | CA2799181A1 Ospa chimeras and use thereof in vaccines |
11/17/2011 | CA2799169A1 Chlorotoxin variants, conjugates, and methods for their use |
11/17/2011 | CA2799095A1 Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof |
11/17/2011 | CA2798905A1 Growth promoting fusion proteins |
11/17/2011 | CA2792314A1 Modulation of scleraxis using a dominant negative scleraxis mutant with a basic dna-binding domain deletion |
11/17/2011 | CA2784666A1 Modified clostridial toxins comprising an integrated protease cleavage site-binding domain |
11/16/2011 | EP2386859A2 Diagnostic tumor markers |
11/16/2011 | EP2386639A2 Modified pore-forming protein toxins and use thereof |
11/16/2011 | EP2386635A2 Mutant G-protein coupled receptors (GPCR) and methods for selecting them |
11/16/2011 | EP2386575A2 Dual specificity antibodies and methods of making and using |
11/16/2011 | EP2386573A1 Transgenic animal with enhanced immune response and method for the preparation thereof |
11/16/2011 | EP2386572A1 Insulin derivative |
11/16/2011 | EP2386571A2 Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
11/16/2011 | EP2386570A1 Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies and compositions thereof |
11/16/2011 | EP2386569A1 Alpha-amylase mutants |
11/16/2011 | EP2386568A1 Alpha-amylase mutants |